Quick Answer
Cellebrite DI Ltd. reported R&D Expense of $113.88 million for fiscal year 2025.
Cellebrite DI Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $113.88M | +15.7% |
| 2024 | $98.42M | +16.6% |
| 2023 | $84.39M | +4.7% |
| 2022 | $80.62M | +23.0% |
| 2021 | $65.54M | +20.5% |
| 2020 | $54.38M | +16.8% |
| 2019 | $46.57M | — |
- Cellebrite DI Ltd. showed an increase of +15.7% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, Cellebrite DI Ltd.’s r&d expense has grown by 144.5% (from $46.57 million to $113.88 million).
- The most recent figure is from Cellebrite DI Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: